▲ Peaking
Business
🔮 fades ✓
FDA offers new details on quicker approval pathway for personalized gene therapies
Faster approval for gene therapies could bring hope to patients with rare diseases.
Rare Diseases
12 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Rare Diseases
This hub groups 12 separate news trends connected to Rare Diseases, spanning June 19, 2026 through October 28, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 78 article observations and 73 source signals, led by Health, Business, World coverage. Use it to compare how individual events emerged, spread and changed over time.
↑ Rising
World
🔮 fades ✓
Roche’s changing plans show how MFN is complicating European drug launches
6 news sources are covering this World story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Her son was dying, but his rare cancer made it difficult to get the right drug
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
These parents didn’t know why their daughter was sick. They turned to AI to help solve the mystery.
Parents are turning to AI tools like ChatGPT to finally pinpoint elusive rare diseases in their children.
◼ Archived
Business
🔮 fades ✓
RK Mellon Foundation pledges $25M to launch rare disease therapy hub in Pittsburgh - Pittsburgh Post-Gazette
The RK Mellon Foundation's $25M investment aims to transform Pittsburgh into a hub for rare disease therapies.
◼ Archived
Health
🔮 fades ✗
Targeting Allele-Specific Faulty MRNA In SCNA2 Mutation Patients
8 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition
Anthropic is aggressively expanding into the biopharma sector through a 100-day sprint involving Nobel hires, M&A activity, and new research tools.
◼ Archived
Health
🔮 fades ✓
Boston Children’s and the Broad Institute partner on new center for rare genetic diseases
Three major institutions have launched the Center for Therapeutic Genetics to develop medicines for rare and ultra-rare genetic diseases.
◼ Archived
Health
🔮 fades ✓
Too Much Happiness Sent A Woman To The Emergency Room In an Incredibly Rare Case
A rare medical occurrence known as 'Happy Heart Syndrome' has led to the hospitalization of a woman following her daughter's wedding.
◼ Archived
Business
🔮 holds ✓
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex Pharmaceuticals is expanding into endocrinology with a record-breaking $10 billion acquisition of biotech specialist Crinetics.
◼ Archived
Health
🔮 fades ✓
AI helped diagnose 18 children whose rare diseases had stumped doctors
AI has successfully diagnosed 18 children with rare diseases that had previously baffled medical professionals.